Cleeland C S
Cancer. 1984 Dec 1;54(11 Suppl):2635-41. doi: 10.1002/1097-0142(19841201)54:2+<2635::aid-cncr2820541407>3.0.co;2-p.
Pain is one of the most feared consequences of cancer. Until recently, however, little has been known about its prevalence, severity, and impact on the patient with cancer. The presence of pain, despite efforts to treat it, represents a continued source of frustration for patients, their families, and the health care team. Although often one of the early indicators of the presence of disease, pain is not a significant problem for the majority of patients in the early stages of disease, with 5% to 10% of patients with solid tumors reporting pain at a level that interferes with mood and activity. But when metastatic disease is present, about one in three patients reports significant pain, and our data and those of others indicate that the majority of patients with end-stage disease will report pain of a severity that interferes with several aspects of the patient's quality of life. Site of tumor is also significantly related to the progression of pain. The relationship between pain intensity and depression and anxiety is examined in detail, and the treatment implications of this relationship discussed. Whereas a modest relationship between pain intensity and depression has been found across several studies, the possibility that depression is a causative factor in the pain experienced by the cancer patient may have been overemphasized. Data on the relief of pain in cancer are reported from the perspective of patients as well as the physicians and nurses who treat them. The majority of physicians and nurses specializing in cancer treatment whom we have surveyed believe that cancer patients in general are undermedicated for pain. Patient survey data indicate that only 50% of cancer patients with pain report 70% or greater pain relief with analgesic medication. Although a number of nonsystemic treatments may be useful for cancer pain management (such as nerve blocks, neurosurgery, and behavioral treatments), they are not widely available and there are few controlled studies of their effectiveness. Teaching patients to report the level of their pain on simple pain intensity scales has proven useful in monitoring the effectiveness of pain management, as well as in helping establish pain control goals for the individual patient.
疼痛是癌症最可怕的后果之一。然而,直到最近,人们对其在癌症患者中的患病率、严重程度及影响仍知之甚少。尽管采取了治疗措施,但疼痛的存在仍是患者、其家人及医护团队持续沮丧的根源。虽然疼痛常常是疾病存在的早期指标之一,但在疾病早期,大多数患者的疼痛问题并不严重,只有5%至10%的实体瘤患者报告疼痛程度影响了情绪和活动。但当出现转移性疾病时,约三分之一的患者报告有严重疼痛,我们的数据及其他研究数据表明,大多数终末期疾病患者报告的疼痛严重程度会影响患者生活质量的多个方面。肿瘤部位也与疼痛进展显著相关。详细研究了疼痛强度与抑郁和焦虑之间的关系,并讨论了这种关系对治疗的影响。尽管多项研究发现疼痛强度与抑郁之间存在适度关联,但抑郁是癌症患者疼痛的致病因素这一可能性可能被过度强调了。从患者以及治疗他们的医生和护士的角度报告了癌症疼痛缓解的数据。我们调查的大多数专门从事癌症治疗的医生和护士认为,癌症患者总体上镇痛药物治疗不足。患者调查数据表明,只有50%有疼痛的癌症患者报告使用镇痛药后疼痛缓解了70%或更多。尽管一些非全身性治疗方法可能对癌症疼痛管理有用(如神经阻滞、神经外科手术和行为治疗),但它们并不广泛可用,且对其有效性的对照研究很少。事实证明,教导患者用简单的疼痛强度量表报告疼痛程度,有助于监测疼痛管理的效果,也有助于为个体患者确立疼痛控制目标。